Bayer Schering Pharma Cash Flow Statement
View: Annual | Quarterly
| Dec 05 | Dec 04 | Dec 03 | |
|---|---|---|---|
| Net Operating Cash Flow | 1,241.3 | 1,024.7 | 732.0 |
| Net Investing Cash Flow | (457.2) | (424.3) | (203.0) |
| Net Financing Cash Flow | (747.4) | (296.1) | (311.0) |
| Net Change in Cash | 53.3 | 298.8 | 199.0 |
| Depreciation & Amortization | 412.2 | 416.1 | 393.0 |
| Capital Expenditures | -- | -- | (400.0) |
| Cash Dividends Paid | (228.6) | (245.6) | (227.0) |




